Analyst Pietro Nargi of Intermonte maintained a Buy rating on Esprinet Spa (0NFS – Research Report), reducing the price target to €6.30.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Pietro Nargi has given his Buy rating due to a combination of factors including Esprinet Spa’s strong performance in key markets and segments. The company has shown robust sales growth, particularly in Spain and Portugal, with significant increases in its value-added segments such as Solutions and Services. Additionally, the newly launched green tech division, Zeliatech, has also contributed positively to the company’s growth.
Despite a cautious guidance on FY25 EBITDA due to market volatility, Esprinet is strategically focusing on optimizing its cost structure and improving working capital dynamics. The company is well-positioned to capture market share in the high-margin solutions segment and is exploring potential mergers and acquisitions to expand its market presence. While the guidance is conservative, the company’s strategic initiatives and market positioning support a positive outlook, justifying the Buy rating with a target price of €6.30.
In another report released on May 15, Intesa Sanpaolo also reiterated a Buy rating on the stock with a €6.00 price target.